Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial

被引:87
|
作者
Jones, RC [1 ]
Francis, GS [1 ]
Lauer, MS [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1016/j.jacc.2004.05.077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We identified predictors of mortality in patients with preserved ejection fraction (EF) and clinical heart failure (HF). BACKGROUND Although diastolic HF is common, the factors that predict mortality have not been clearly defined. METHODS We studied 988 patients with HF and preserved EF enrolled in the Digitalis Investigation Group (DIG) trial. Survival analyses were employed to identify variables associated with mortality. RESULTS During 3.1 years of follow-up, 231 (23%) patients died. Among 18 variables considered, the strongest independent predictors of death were glomerular filtration rate (adjusted hazard ratio for one standard deviation decrease 1.50, 95% confidence interval [CI] 1.35 to 1.67, p < 0.0001), New York Heart Association functional class III or TV (adjusted hazard ratio 1.64, 95% CI 1.20 to 2.18, p = 0.0011), male gender (adjusted hazard ratio 1.71, 95% CI 1.26 to 2.32, p = 0.0005), and older age (adjusted hazard ratio for one standard deviation increase of age 2 1.28, 95% Cl 1.08 to 1.50, p = 0.0019). A risk score was developed to estimate long-term mortality. CONCLUSIONS Diastolic HF is associated with a high death rate. Important predictors of death include impaired renal function, worse functional class, male gender, and older age. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:1025 / 1029
页数:5
相关论文
共 50 条
  • [31] Nutritional status and its impact on mortality in patients with heart failure with preserved or depressed systolic function, are there differences?
    Pachon, J. C.
    Bonilla Palomas, J. L.
    Gamez Lopez, A. L.
    Moreno Conde, M.
    Lopez Ibanez, C.
    Soriano Yanes, B. C.
    Anguita Sanchez, M. P.
    Castillo Dominguez, J. C.
    Lopez Lopez, J. M.
    Villar Raez, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 641 - 642
  • [32] Coronary artery disease in patients with heart failure and preserved systolic function
    Choudhury, L
    Gheorghiade, M
    Bonow, RO
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (06): : 719 - +
  • [33] Heart failure with a preserved systolic function and diastolic heart failure are not synonymous
    Eicher, J. -C.
    Barthez, O.
    Saint-Pierre, F.
    Dobsak, P.
    Wolf, J. -E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 844 - 845
  • [34] Predictors of mortality in icd implanted patients with chronic systolic heart failure
    Bogyi, PPeter
    Muk, B.
    Dekany, M.
    Szabo, B.
    Borsanyi, T.
    Majoros, Z. S.
    Vamos, M.
    Duray, G. Z.
    Kiss, R. G.
    Nyolczas, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 195 - 195
  • [35] Effectiveness of Digoxin in Reducing One-Year Mortality in Chronic Heart Failure in the Digitalis Investigation Group Trial
    Ahmed, Ali
    Waagstein, Finn
    Pitt, Bertram
    White, Michel
    Zannad, Faiez
    Young, James B.
    Rahimtoola, Shahbudin H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (01): : 82 - 87
  • [36] Incidence and clinical predictors of late development of heart failure in patients with acute myocardial infarction and preserved systolic function
    Aronson, D.
    Agmon, Y.
    Suleiman, A.
    Kapeliovich, M.
    Beyar, R.
    Hammerman, H.
    Markiewicz, W.
    EUROPEAN HEART JOURNAL, 2007, 28 : 420 - 420
  • [37] Digoxin and reduction in early mortality in chronic heart failure: insights into the lack of late mortality reduction in the digitalis investigation group trial
    Ahmed, A.
    Zannad, F.
    Young, J. B.
    Waagstein, F.
    White, M.
    Rahimtoola, S. R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 46 - 47
  • [38] Coronary Microcirculation in Heart Failure with Preserved Systolic Function
    Vasiljevic, Zorana
    Krljanac, Gordana
    Zdravkovic, Marija
    Lasica, Ratko
    Trifunovic, Danijela
    Asanin, Milika
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (25) : 2960 - 2966
  • [39] Risk factors for heart failure with preserved systolic function
    Uchino, K
    Ishigami, T
    Sugano, T
    Nakazawa, I
    Ogawa, H
    Kobayashi, T
    Matsushita, K
    Matsumoto, K
    Ishikawa, T
    Umemura, S
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S308 - S308
  • [40] Retransplantation for heart failure with preserved systolic function.
    Gokanapudy, L.
    Itagaki, B. K.
    Kobashigawa, J. A.
    Wu, G. W.
    Brubaker, W. D.
    Kawano, M. A.
    Kittleson, M. M.
    Hamilton, M. A.
    Patel, J. K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S137 - S137